A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Clinical trial NCT07282600 · RECRUITING

Trial details

NCT number: NCT07282600
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Overweight Obesity

Start date: 2025-12-15
Primary completion: 2028-01-01
Enrollment: 1035

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.